ReviewCurrent oncology (Toronto, Ont.)2018

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials.

G M O'Kane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.